Article Details

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement

Retrieved on: 2021-06-02 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement. View article details on hiswai:

Excerpt

Ligand's OmniAb® technology platform is a patent-protected technology stack used in the discovery of fully human mono- and bispecific therapeutic ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up